文献速递临床试验与 GCP真实世界研究与卫生经济

脊髓电刺激筛选试验对神经病理性疼痛患者的临床效用与成本效果:TRIAL-STIM随机对照试验方案

Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2018-11-16

TRIAL-STIM研究是一项优越性、平行组、三中心随机对照试验,纳入100例接受脊髓电刺激(SCS)植入的慢性神经病理性疼痛成人,1:1随机分为筛选试验后植入组与直接植入组,主要结局为6个月时数值评定量表(NRS)评分,并嵌套定性研究与成本效用分析。

要点

  • 评估SCS植入前筛选试验的诊断性能、临床结局与成本效果。
  • 主要结局为6个月NRS评分,筛选试验组与直接植入组比较。
  • 嵌套定性研究每中心10例患者,探索患者对筛选试验和植入的看法。

核心结论

  • TRIAL-STIM研究旨在确定SCS筛选试验的临床效用与成本效果。

研究设计与样本

  • 优越性、平行组、三中心随机对照试验,嵌套定性研究与经济评价。
  • 计划纳入100例接受SCS植入治疗神经病变的成人,从三个中心门诊招募。
  • 按1:1随机分为筛选试验后植入组与直接植入组,按中心分层并按年龄、性别、失败背部手术综合征及高频(HF10™)使用最小化。

关键数值与推荐

  • 主要结局为6个月时数值评定量表(NRS)评分,比较筛选试验策略与直接植入策略。
  • 次要结局包括诊断准确性、6个月NRS疼痛缓解至少50%和30%的患者比例、EQ-5D、Oswestry功能障碍指数、患者总体印象变化及并发症率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The TRIAL-STIM Study aims to assess the diagnostic performance, clinical outcomes and cost-effectiveness of a screening trial prior to full implantation of a spinal cord stimulation (SCS) device. METHODS/DESIGN: The TRIAL-STIM Study is a superiority, parallel-group, three-centre, randomised controlled trial in patients with chronic neuropathic pain with a nested qualitative study and economic evaluation. The study will take place in three UK centres: South Tees Hospitals NHS Foundation Trust (The James Cook University Hospital); Basildon and Thurrock University Hospitals NHS Foundation Trust; and Leeds Teaching Hospitals NHS Trust. A total of 100 adults undergoing SCS implantation for the treatment of neuropathy will be included. Subjects will be recruited from the outpatient clinics of the three participating sites and randomised to undergo a screening trial prior to SCS implant or an implantation-only strategy in a 1:1 ratio. Allocation will be stratified by centre and minimised on patient age (≥ 65 or < 65 years), gender, presence of failed back surgery syndrome (or not) and use of high frequency (HF10™) (or not). The primary outcome measure is the numerical rating scale (NRS) at 6 months compared between the screening trial and implantation strategy and the implantation-only strategy. Secondary outcome measures will include diagnostic accuracy, the proportion of patients achieving at least 50% and 30% pain relief at 6 months as measured on the NRS, health-related quality-of-life (EQ-5D), function (Oswestry Disability Index), patient satisfaction (Patients' Global Impression of Change) and complication rates. A nested qualitative study will be carried out in parallel for a total of 30 of the patients recruited in each centre (10 at each centre) to explore their views of the screening trial, implantation and overall use of the SCS device. The economic evaluation will take the form of a cost-utility analysis. DISCUSSION: The TRIAL-STIM Study is a randomised controlled trial with a nested qualitative study and economic evaluation aiming to determine the clinical utility of screening trials of SCS as well as their cost-effectiveness. The nested qualitative study will seek to explore the patient's view of the screening trials, implantation and overall use of SCS. TRIAL REGISTRATION: ISRCTN, ISRCTN60778781 . Registered on 15 August 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Eldabe S, Gulve A, Thomson S, et al. Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial. Trials. 2018. PMID: 30446003. doi:10.1186/s13063-018-2993-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。